-+ 0.00%
-+ 0.00%
-+ 0.00%

Co-Diagnostics FY 2024 GAAP EPS $(1.24) Misses $(1.22) Estimate, Sales $3.900M Miss $4.141M Estimate

Benzinga·03/27/2025 20:04:23
Listen to the news
Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(1.24) per share which missed the analyst consensus estimate of $(1.22) by 1.64 percent. The company reported quarterly sales of $3.900 million which missed the analyst consensus estimate of $4.141 million by 5.82 percent.